Ertugliflozin Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS): A Descriptive Pharmacovigilance Analysis (2013-2026)
Fields of Study & Subjects
Pharmacovigilance and Adverse Drug Reactions
Diabetes Treatment and Management
Patient Safety and Medication Errors
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 12 March 2026
- Language
- EN